imcannabis.com (IMCC): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

IM Cannabis Corp. (IMCC) logistics rely on licensed warehouses and hubs in Germany and Israel, utilizing long-term agreements with greenhouses. Business growth is driven by the premium segment and the legalization of cannabis in Germany. The market capitalization trend on GURU.Markets recorded a value of 0.00, reflecting EV/EBITDA dynamics. The operator has currently ceased mergers, focusing instead on internal development and maintaining its market positions.

IMCC IM Cannabis: Enterprise Value to EBITDA Ratio in the range 11/23/2025 - 11/12/2026

Summary analytical data breakdowns for imcannabis.com (IMCC)

- current price and projected stock value:

Stock Price IM Cannabis|IMCC - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value IM Cannabis Corp.|IMCC - Value Adjusted for Debt and Cash

- book value of equity indicators:

Net Assets per Single Share IM Cannabis|IMCC - Company Net Assets|Market Capitalization to Book Value Ratio imcannabis.com|IMCC - Company Total Asset Base

- debt and solvency information:

- business earnings and investment ratios data:

IMCC - Company Profit|Expected Profit IM Cannabis Corp.|IMCC - Price to Earnings Multiple|Forward P/E Multiple IM Cannabis|IMCC - PEG Multiple|EV/EBITDA Multiple IM Cannabis Corp.|IMCC - Profit before payment of interest, taxes and amortization|Net earnings per share (EPS TTM) IM Cannabis|IMCC - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months imcannabis.com|IMCC - Expected net earnings per share growth this year|Expected earnings per share growth for next year IM Cannabis Corp.

Summary company analysis:IMC IMCC

This indicator compares the total enterprise value with its operating profit before depreciation and interest, allowing for an assessment of the real value of assets without the influence of debt load. Amid the expansion of IM Cannabis Corp. (IMCC) into European and Israeli markets, the trend of the base EV/EBITDA multiple reflects the efficiency of premium brand monetization and the risks of overpaying for capitalization within the legal cannabis sector.

Competitors of IM Cannabis Corp. (IMCC)

EV/EBITDA Multiple INDV (Indivior Group)|EV/EBITDA Multiple Collegium Corp COLL|CRON - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation CGC (canopygrowth.com)|High Tide (HITI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Aurora Cannabis Inc.|ACHV (Achieve Life Sciences, Inc) - EV/EBITDA Multiple|skyebioscience.com (SKYE) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anebulo Pharmaceuticals (ANEB)|Enterprise Value to EBITDA Ratio intercure.co INCR|Nutriband - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation NSRX|IGC Pharma Inc - EV/EBITDA Multiple|MIRA Pharmaceuticals (MIRA) - Enterprise Value to EBITDA Ratio|FLGC: EV/EBITDA Multiple|Adial Pharmaceuticals, Inc. (ADIL) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artelo Biosciences Inc.|Enterprise Value to Operating Income Before Depreciation ENSC (Ensysce)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Titan Pharmaceuticals (TTNP)|Greenlane Corp - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple INM (InMed Pharmaceuticals)|EV/EBITDA Multiple akandacorp.com AKAN|Enveric Biosciences, Inc. - EV/EBITDA Multiple|BGXX: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HPCO: EV/EBITDA Multiple